(July 30, 2026)The big health consumer market keeps expanding, creating a window for domestic substitution of compliant high-purity silica for food and pharmaceutical applications. As regulatory standards for health supplements, pharmaceutical preparations and food additives continue to tighten, China and many overseas countries have updated access specifications for food-contact materials and pharmaceutical excipients. Demand for high-purity compliant silica is steadily rising. Special silica for food and pharmaceutical use mainly serves as an anti-caking agent, drug carrier and glidant. Thanks to strict impurity control, it has become an indispensable functional powder in the health consumer sector and opened up a brand-new growth track for the silica industry.
For a long time, high-end food-grade and pharmaceutical-grade silica has relied heavily on imported overseas products. Ordinary industrial silica fails to meet standards in heavy metals and trace impurities, and lacks sound microbial control systems, which makes it unable to satisfy pharmacopoeia requirements and safety specifications for food additives. Food & pharma-grade silica produced via deep purification and dust-free manufacturing features stable physicochemical properties with outstanding adsorption and flow regulation capacity. Hydrophilic grades are widely used to prevent caking in solid health powders, milk powder and seasoning powder. High-purity modified products are suitable for pharmaceutical sustained-release carriers and medical packaging silicone rubber. They can effectively avoid powder agglomeration, extend shelf life, and meet raw material compliance demands of health consumer manufacturers at home and abroad.
In the second half of 2026, food and solid pharmaceutical enterprises enter the stock preparation cycle. Overseas brands increase procurement of compliant raw materials, and importers give priority to domestic powder with complete certifications. Market supervision authorities across regions strengthen source control over food additives, forcing downstream enterprises to phase out non-compliant fillers. Leading domestic silica enterprises keep constructing GMP dust-free production lines and establish complete testing and traceability systems. They develop graded high-purity grades in line with FDA standards, China’s national standards for food additives and pharmaceutical excipient criteria. Many powder companies carry out joint formula verification with pharmaceutical research institutes, and develop customized filler solutions for oral solid preparations, nutritional powders and medical sealing silicone.
Different food and pharmaceutical scenarios impose differentiated indicator requirements on silica. Solid pharmaceutical preparations require strict control over heavy metals and soluble impurities to comply with pharmacopoeia standards; powdered food and dietary supplements focus on flowability and anti-caking performance; food-contact silicone rubber products balance purity and reinforcing processing performance; carriers for external medical dressings set extremely strict thresholds for powder irritation and microbial indicators. A single grade cannot cover diverse compliant scenarios, driving enterprises to build a graded compliant product portfolio. Leading pharmaceutical companies and large food groups implement lengthy raw material qualification procedures, continuously raising market entry barriers.
The track boasts promising prospects while industrial challenges remain. Food & pharma-grade silica demands strict standards for production cleanliness and full-process microbial control. Upfront investment in production line renovation and certification is substantial. Established overseas enterprises have long dominated high-end supply chains, and market recognition of domestic products still needs cultivation. Numerous small and medium powder manufacturers lack full-set compliance testing capabilities and cannot enter formal food and pharmaceutical industrial chains. Besides, small quantities of low-cost non-standard powder circulating in the market harm the overall reputation of domestic powder products.
Market differentiation in the industry keeps intensifying. Leading enterprises that take early steps to build dust-free production lines, master deep purification technologies and hold complete compliance certifications achieve continuous order growth. Manufacturers without compliance qualifications that only produce general industrial powder are excluded from the food and pharmaceutical track. The downstream health industry accelerates concentration, and procurement resources keep converging to upstream powder suppliers with stable quality control and complete credentials.
Industrial research institutes predict that global supervision over food and pharmaceutical excipients will keep tightening in the next three years alongside steady expansion of the big health industry. The market scale of compliant high-purity silica will maintain an upward trend. Featuring high added value and stable demand, this track enables silica manufacturers to escape homogeneous competition in the tire sector and enter the high-end fine powder market.
In the long run, developing high-purity silica dedicated to food and pharmaceutical use helps domestic silicon-based powder enterprises accelerate import substitution of high-end fine fillers. Domestic manufacturers shall continuously optimize deep purification and clean production technologies, and complete global safety certifications related to food and pharmaceutical products. Strengthen upstream and downstream collaborative R&D with pharmaceutical and food processing enterprises, iterate functional carrier fillers for new-generation health consumer goods, and elevate the competitive position of domestic high-purity silica in the global pharmaceutical and food additive market.